XCL1 Antikörper

Produktnummer ABIN636704

Produktdetails anti-XCL1 Antikörper

Target: XCL1 (Chemokine (C Motif) Ligand 1 (XCL1))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser XCL1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Blocking Antibody (Inhibition)

Aufreinigung: Purified

Immunogen: Lymphotactin antibody was raised in rabbit using highly pure recombinant human lymphotactin as the immunogen.

Anwendungsinformationen

Applikationshinweise: ELISA: 0.5-2 µg/mL, Inhibition: 1.70-3 µg/mL, WB: 0.1-0.2 µg/mL
Optimal conditions should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized from PBS, pH 7.2.

Handhabung: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at -20 °C until reconstitution. Following reconstitution product may be stored at 4 °C in the short term. For long term storage aliquot and freeze at -20 °C.

Details zu XCL1

Target: XCL1 (Chemokine (C Motif) Ligand 1 (XCL1))

Andere Bezeichnung: Lymphotactin (XCL1 Produkte)

Synonyme: ATAC antikoerper, LPTN antikoerper, LTN antikoerper, SCM-1 antikoerper, SCM-1a antikoerper, SCM1 antikoerper, SCM1A antikoerper, SCYC1 antikoerper, AI661682 antikoerper, Lptn antikoerper, Scyc1 antikoerper, Ltn antikoerper, XCL1 antikoerper, XCL2 antikoerper, X-C motif chemokine ligand 1 antikoerper, chemokine (C motif) ligand 1 antikoerper, cytokine SCM-1 beta antikoerper, lymphotactin antikoerper, XCL1 antikoerper, Xcl1 antikoerper, LOC490356 antikoerper, LOC100714756 antikoerper, LOC100349255 antikoerper

Hintergrund: Lymphotactin is the only known member of the C-chemokine family and signals through the receptor XCR1, formally known as GPR5. The spleen shows the highest level of lymphotactin compared to peripheral leukocytes, lung, colon and small intestine.

Molekulargewicht: 10.0 kDa (predicted detection band MW)

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation